Studying the effect of retinopathy of prematurity screening on cerebral and gut regional oxygenation.
Recruiting
- Conditions
- PrematurityRetinopathy of Prematurity
- Registration Number
- ACTRN12618000773235
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link ROP screening to cerebral oxygenation changes in preterm infants?
How does ROP-Ox observational study compare to standard-of-care in managing retinopathy of prematurity?
Are there specific biomarkers that correlate with improved cerebral and gut oxygenation post-ROP screening?
What adverse events are associated with ROP screening in neonates and how are they managed?
How do cerebral and splanchnic oxygenation dynamics in ROP-Ox relate to other neonatal neuroprotection trials?